This role combines strategic planning and scientific engagement to support medical initiatives. It involves close collaboration with healthcare stakeholders to improve patient care and shape national treatment pathways.
Description
- Develop and execute medical strategies aligned with global objectives.
- Build strong relationships with healthcare professionals, patient groups, and decision-makers to share scientific insights and gather feedback.
- Act as a medical expert across internal teams, contributing to strategic discussions and providing training on disease areas and products.
- Support research initiatives, including real-world data and investigator-led studies, and contribute to scientific publications.
- Analyse market trends, identify new opportunities, and support business decisions through client engagement and account strategies.
- Ensure all activities meet regulatory standards and promote a culture of transparency, accuracy, and scientific integrity.
Profile
- Minimum of 2-3 years in medical affairs or pharmaceutical marketing, preferably in rare diseases or speciality care.
- Proven ability to build scientific peer-to-peer relationships with external experts.
- In-depth understanding of the Portuguese healthcare ecosystem.
- Solid grasp of pharmaceutical industry regulations and compliance standards.
- Possesses an advanced degree in Life Sciences, with additional qualifications in pharmaceutical or business studies.
- Proficient in Portuguese and English, with Spanish regarded as an additional advantage.
Job Offer
This role offers the opportunity to lead strategic medical initiatives in a dynamic and impactful therapeutic area, contributing directly to patient outcomes and innovation in rare diseases. The candidate will benefit from a hybrid working model, cross-functional collaboration, and visibility across national and international teams. It's a chance to grow professionally within a global biopharmaceutical environment that values scientific excellence, ethical integrity, and patient-centricity.